Pages that link to "Q40633092"
Jump to navigation
Jump to search
The following pages link to Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors (Q40633092):
Displaying 50 items.
- Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling (Q24294906) (← links)
- Role of Rap1B and tumor suppressor PTEN in the negative regulation of lysophosphatidic acid--induced migration by isoproterenol in glioma cells (Q24657979) (← links)
- Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6 (Q24658261) (← links)
- Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain (Q27329693) (← links)
- Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression (Q27334635) (← links)
- Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate (Q28260852) (← links)
- Targeting lysophosphatidic acid signaling retards culture-associated senescence of human marrow stromal cells (Q28480919) (← links)
- A metabolically-stabilized phosphonate analog of lysophosphatidic acid attenuates collagen-induced arthritis (Q28534911) (← links)
- Lysophosphatidic acid alters the expression profiles of angiogenic factors, cytokines, and chemokines in mouse liver sinusoidal endothelial cells (Q28545165) (← links)
- The role of LPA1 in formation of synapses among cultured hippocampal neurons (Q28572196) (← links)
- Unmasking of LPA1 receptor-mediated migration response to lysophosphatidic acid by interleukin-1β-induced attenuation of Rho signaling pathways in rat astrocytes (Q28583908) (← links)
- Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors (Q30410634) (← links)
- Development of a phosphatase-resistant, L-tyrosine derived LPA1/LPA3 dual antagonist (Q30427967) (← links)
- International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature (Q30429523) (← links)
- Learning therapeutic lessons from metastasis suppressor proteins (Q30435922) (← links)
- Role of LPA4/p2y9/GPR23 in negative regulation of cell motility (Q30440331) (← links)
- The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors (Q30486707) (← links)
- Rho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acid (Q30538666) (← links)
- Distinct phospholipase C-β isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure (Q30539636) (← links)
- Lysophosphatidic acid signaling may initiate fetal hydrocephalus. (Q30539772) (← links)
- Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity. (Q30573574) (← links)
- Rapid Remodeling of Invadosomes by Gi-coupled Receptors: DISSECTING THE ROLE OF Rho GTPases. (Q30734428) (← links)
- Role of ectonucleotide pyrophosphatase/phosphodiesterase 2 in the midline axis formation of zebrafish (Q30829645) (← links)
- Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device (Q30843450) (← links)
- 2D binary QSAR modeling of LPA3 receptor antagonism (Q33548210) (← links)
- Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers (Q33610285) (← links)
- Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells (Q33786333) (← links)
- Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells (Q33809139) (← links)
- Inositol phosphate recycling regulates glycolytic and lipid metabolism that drives cancer aggressiveness (Q33824915) (← links)
- LPA receptor signaling: pharmacology, physiology, and pathophysiology (Q33825153) (← links)
- Role of TAZ in Lysophosphatidic Acid-Induced Migration and Proliferation of Human Adipose-Derived Mesenchymal Stem Cells (Q33878267) (← links)
- Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer (Q33972424) (← links)
- Lysophospholipid receptor nomenclature review: IUPHAR Review 8. (Q34025135) (← links)
- Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway (Q34085728) (← links)
- Diversity of lysophosphatidic acid receptor-mediated intracellular calcium signaling in early cortical neurogenesis (Q34100704) (← links)
- A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model (Q34116805) (← links)
- p2y5/LPA(6) attenuates LPA(1)-mediated VE-cadherin translocation and cell-cell dissociation through G(12/13) protein-Src-Rap1. (Q34189057) (← links)
- ATX-LPA receptor axis in inflammation and cancer (Q34199719) (← links)
- Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity (Q34250421) (← links)
- Gintonin, a ginseng-derived novel ingredient, evokes long-term potentiation through N-methyl-D-aspartic acid receptor activation: involvement of LPA receptors (Q34312433) (← links)
- Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma (Q34314916) (← links)
- Aiming drug discovery at lysophosphatidic acid targets (Q34339759) (← links)
- Lysophosphatidic acid induces integrin activation in vascular smooth muscle and alters arteriolar myogenic vasoconstriction (Q34433358) (← links)
- The PDZ protein GIPC regulates trafficking of the LPA1 receptor from APPL signaling endosomes and attenuates the cell's response to LPA. (Q34474291) (← links)
- Protection of neuroblastoma Neuro2A cells from hypoxia-induced apoptosis by cyclic phosphatidic acid (cPA). (Q34516098) (← links)
- Gintonin facilitates catecholamine secretion from the perfused adrenal medulla (Q34544740) (← links)
- The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases (Q34687134) (← links)
- Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling (Q35216929) (← links)
- Diverse roles of LPA signaling in the intestinal epithelium (Q35533312) (← links)
- The basic secretagogue compound 48/80 activates G proteins indirectly via stimulation of phospholipase D-lysophosphatidic acid receptor axis and 5-HT1A receptors in rat brain sections. (Q35545353) (← links)